间接胆红素在肝切除术安全评估中的临床价值

Assessment of safety in hepatic resection focusing on indirect hyperbilirubinemia

关键词:  肝细胞肝癌  肝切除术  胆红素

Key words:  [Key words]　hepatocellular carcinoma  hepatectomy  bilirubin

摘要:

〗[摘要]　目的　探讨间接胆红素在肝切除术安全评估方面的临床价值。　方法　回顾性分析2003年1月—2013年12月73例行肝切除术的肝硬化合并肝细胞癌患者的临床资料，将正常胆红素组（22例）与总胆红素＞19 μmol/L，直接胆红素＜8.5 μmol /L的高胆红素组（51例）临床指标进行对比分析，对两组肝切除术后的肝衰竭发生率进行比较。　结果　两组患者术前凝血酶原时间，术前白蛋白水平，手术时间，术中出血量差异均无显著性意义（P>0.05），两组患者肝功能衰竭发生率差异亦无显著性意义（P>0.05）。　结论　高总胆红素低直接胆红素患者与正常胆红素患者具备同样的肝切除手术安全性。

Abstract:

[Abstract]　Objective　To investigate the clinical value of indirect bilirubin in the safety assessment of liver resection. 　Methods　Through retrospective analysis 73 patients of hepatocellular carcinoma with cirrhosis underwent hepatic resection in our hospital from January 2003 to December 2013, the clinical indicators of total bilirubin of normal level (22 cases) and total bilirubin more than 19 μmol/L direct bilirubin less than 8.5 μmol/L in patients (51 cases) were analyzed, hepatic failure incidence of the two groups after hepatectomy were analyzed. 　Results　The prothrombin time, serum albumin，operation time, intraoperative bleeding were similar in the two groups (P>0.05).There were no significant differences in hepatic failure incidence of the two groups(P>0.05).　Conclusion　High total bilirubin and low direct bilirubin in patients have the same security of hepatic resection with normal bilirubin in patients.